Physician Data Query

Last uploaded: August 28, 2024
Preferred Name

dianhydrogalactitol
Synonyms

DAG

dulcitol diepoxide

diepoxygalactitol

galactitol, 1,2:5,6-dianhydro- (8CI 9CI)

dianhydrodulcitol

1,2:5,6-dianhydrodulcitol

1,2:5,6 dianhydrogalactitol

1,2:5, 6-diepoxydulcitol

galactitol

diepoxydulcitol

1,2,5,6 dianhydrogalactitol

Definitions

A bifunctional hexitol derivative with potential antineoplastic activity. Dianhydrogalactitol alkylates and cross-links DNA via an epoxide group during all phases of the cell cycle, resulting in disruption of DNA function and cell cycle arrest. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C425" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C425" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000039215

altLabel

DAG

dulcitol diepoxide

diepoxygalactitol

galactitol, 1,2:5,6-dianhydro- (8CI 9CI)

dianhydrodulcitol

1,2:5,6-dianhydrodulcitol

1,2:5,6 dianhydrogalactitol

1,2:5, 6-diepoxydulcitol

galactitol

diepoxydulcitol

1,2,5,6 dianhydrogalactitol

CAS Registry

23261-20-3

Component of

http://purl.bioontology.org/ontology/PDQ/CDR0000039536

http://purl.bioontology.org/ontology/PDQ/CDR0000039354

http://purl.bioontology.org/ontology/PDQ/CDR0000039532

cui

C0011967

C0013283

definition

A bifunctional hexitol derivative with potential antineoplastic activity. Dianhydrogalactitol alkylates and cross-links DNA via an epoxide group during all phases of the cell cycle, resulting in disruption of DNA function and cell cycle arrest. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C425" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C425" NCI Thesaurus)

IND Code

10899

Legacy PDQ ID

1837

NCI ID

C425

notation

CDR0000039215

NSC Code

132313

ORIG STY

Drug/agent

prefLabel

dianhydrogalactitol

tui

T109

T123

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.bioontology.org/ontology/MESH/D003961 MESH CUI
http://purl.bioontology.org/ontology/NDFRT/N0000168409 NDFRT CUI
http://purl.bioontology.org/ontology/NDFRT/N0000168410 NDFRT CUI
http://purl.bioontology.org/ontology/MSHFRE/D003961 MSHFRE CUI
http://purl.bioontology.org/ontology/CSP/2828-4553 CRISP CUI
http://purl.bioontology.org/ontology/LNC/MTHU026383 LOINC CUI
http://purl.bioontology.org/ontology/MESH/D004376 MESH CUI
http://purl.bioontology.org/ontology/SCTSPA/116268004 SCTSPA CUI
http://purl.bioontology.org/ontology/MSHFRE/D004376 MSHFRE CUI
http://purl.bioontology.org/ontology/SNOMEDCT/116268004 SNOMEDCT CUI
http://purl.bioontology.org/ontology/LNC/LP61820-4 LOINC CUI
http://purl.bioontology.org/ontology/RCD/X80Hq RCD CUI
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C425 NCIT LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D003961 RH-MESH LOOM
http://purl.bioontology.org/ontology/MESH/D003961 MESH LOOM
https://go.drugbank.com/drugs/DB12873 MDM LOOM
http://purl.jp/bio/4/id/200906066809493250 IOBC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.033.800.400.350 RH-MESH LOOM
http://purl.obolibrary.org/obo/OMIT_0005234 OMIT LOOM
http://purl.obolibrary.org/obo/NCIT_C425 BERO LOOM
http://stirdf.jst.go.jp/id/200907024890439914 IOBC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D09.853.400.350 RH-MESH LOOM
http://www.phoc.org.cn/pmo/class/PMO_00015764 PMAPP-PMO LOOM
http://purl.obolibrary.org/obo/MESH_D003961 BERO LOOM